Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse

Overview of attention for article published in Blood Cancer Journal, May 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 3 news outlets
policy: 2 policy sources

twitter: 38 X users

Citations

dimensions_citation: 79 Dimensions

Readers on

mendeley: 91 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Fast Five Quiz: Management of Mantle Cell Lymphoma

Medscape, 26 Jan 2023

Mantle cell lymphoma (MCL) is a rare subtype of B-cell non-Hodgkin lymphoma. As with many other B-cell malignancies, MCL…

复星凯特第二款CAR-T细胞治疗药物FKC889获批临床

Ebiotrade, 04 Mar 2022

编辑推荐：上海2022年3月2日 /美通社/ -- 复星凯特生物科技有限公司今日宣布，公司第二款CAR-T细胞治疗药物FKC889针对既往接受过二线及以上治疗后复发或难治性套细胞淋巴瘤（简称r/r MCL）的...

Response Patterns After Multiple Lines of Therapy in Mantle Cell Lymphoma

Medical Health News, 14 Jun 2019

In patients with mantle cell lymphoma (MCL), survival and response duration decrease with successive lines of treatment…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.